Player FM ऐप के साथ ऑफ़लाइन जाएं!
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Manage episode 395746315 series 3506087
Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.
Links
Big thanks to TimePie for the research help for this episode
Rapamycin resources
Connect with Krister on:
Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.
8 एपिसोडस
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Manage episode 395746315 series 3506087
Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.
Links
Big thanks to TimePie for the research help for this episode
Rapamycin resources
Connect with Krister on:
Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.
8 एपिसोडस
All episodes
×1 Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging 1:22:01
1 Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases 1:11:04
1 Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases 1:42:07
1 Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life 1:15:52
1 Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all 1:08:01
1 Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research 2:28:59
1 Alan Green on Rapamycin Longevity Series | Lessons learned from over 1200 patients 1:22:35
1 Ross Pelton on Rapamycin Longevity Series | How it all began 50:18
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।